Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques-Reference-Cited by-同舟云学术

Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques

Published:2006-08-21 Issue:5 Volume:80 Page:1175-1182
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Kennedy Paul E.,Bera Tapan K.,Wang Qing-Cheng,Gallo Maria,Wagner Wendeline,Lewis Mark G.,Berger Edward A.,Pastan Ira

Funder

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1189/jlb.0306139/fullpdf

Reference61 articles.

1. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel;Hammer;JAMA,2006

2. The multifactorial nature of HIV-1 latency;Lassen;Trends Mol. Med.,2004

3. Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1;Shehu-Xhilaga;Curr. Med. Chem.,2005

4. The brightening future of HIV therapeutics;Greene;Nat. Immunol.,2004

5. “Virostatics” as a potential new class of HIV drugs;Kelly;Curr. Pharm. Des.,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1;Vaccines;2023-04-12

2. Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure;Frontiers in Immunology;2021-07-01

3. Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases;Frontiers in Microbiology;2018-12-21

4. Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160;Journal of Virology;2017-02

5. Engineering broadly neutralizing antibodies for HIV prevention and therapy;Advanced Drug Delivery Reviews;2016-08